Litcius/Paper detail

Berdazimer Topical Gel, 10.3%: First Approval

Susan J. Keam

2024Drugs11 citationsDOI

Topics & Concepts

MedicineDermatologyPoxvirus research and outbreaksNail Diseases and TreatmentsTransgenic Plants and Applications
Berdazimer Topical Gel, 10.3%: First Approval | Litcius